I understand your dividend disappointment, but I expected no increase. The company took on $70m of debt to purchase Jundee, I'd rather them focus on paying that off first and happy to note over the last two months debt has decreased by $20m, great result! Annualised that equates to $120m or 20c per share - your extra dividend hasn't gone to waste...remember we should be looking into next year and the years ahead as today's results are only 1/5 the story.
- Forums
- ASX - By Stock
- NST
- Ann: Preliminary Final Report 30 June 2014
Ann: Preliminary Final Report 30 June 2014, page-11
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NST (ASX) to my watchlist
|
|||||
Last
$13.96 |
Change
0.080(0.58%) |
Mkt cap ! $16.04B |
Open | High | Low | Value | Volume |
$14.01 | $14.11 | $13.94 | $6.062M | 432.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 4835 | $13.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.97 | 2317 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 352 | 13.950 |
14 | 2295 | 13.940 |
7 | 1911 | 13.930 |
7 | 6731 | 13.920 |
5 | 3777 | 13.910 |
Price($) | Vol. | No. |
---|---|---|
13.960 | 1630 | 15 |
13.970 | 3369 | 18 |
13.980 | 2798 | 9 |
13.990 | 1737 | 9 |
14.000 | 5535 | 11 |
Last trade - 10.54am 16/07/2024 (20 minute delay) ? |
Featured News
NST (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online